We have earned a coveted spot in the Forbes India SELECT 200, a prestigious recognition of companies with game-changing global business potential!
We have received the Environmental, Social, and Governance (ESG) Certification from Dun & Bradstreet, as a recognition of our commitment to sustainability, social responsibility, and ethical governance. This milestone highlights our efforts to promote health equity through affordable healthcare solutions, adopt sustainable practices, and uphold transparency and compliance.
We have attained the D-U-N-S® Certification from Dun & Bradstreet. This certification enhances our credibility, fosters trust, and streamlines global partnerships, reinforcing our commitment to transparency and excellence in delivering innovative healthcare solutions.
Our in-house R&D Unit has been recognized by the Department of Scientific and Industrial Research (DSIR), Government of India. This certification is crucial for fostering innovation, enabling access to government incentives, and strengthening our research capabilities to develop affordable vaccines, biotherapeutics, and diagnostics.
We have attained the ISO 9001:2015 certification, the international standard for quality management systems. The certification is a testament to an organization's dedication to quality, efficiency, and customer satisfaction, providing a competitive edge in the marketplace.
We have been recognised as a Great Place to Work® for two consecutive years, 2021-2022 and 2022-2023.
The certification is a globally recognized benchmark for identifying and recognizing outstanding employee experiences. Achieving this distinction for two consecutive years testifies to our positive, and healthy environment where employees feel valued and empowered in our inclusive workplace culture.
We have been granted the 80-IAC Tax Exemption Certificate from the Department for Promotion of Industry and Internal Trade (DPIIT), Government of India. This certification is given to startups meeting a number of criterias of which one of focus is innovative business models. This exemption enables us to reinvest savings into research and development.
Recognised as a Deep Tech Pioneer by Hello Tomorrow, a leading global organization dedicated to advancing deep technology solutions underscores our work in leveraging cutting-edge science and technology to create impactful healthcare solutions.
We were featured among the Innovative 100 SMEs by the Innovation Council, Geneva during the World Intellectual Property (IP) Day celebrations in April 2021 for our work on novel products and services.
© 2023 TechInvention. Developed by Scivision Solutions Pvt. Ltd.